ACLY inhibition promotes tumor immunity and suppresses liver cancer,16 demonstrating that ACLY blockade enhances immunogenicity, a finding that complements our observation that Acly activity links metabolic state to inflammatory gene control and may influence sepsis outcomes. The gene discussed is ACLY; the disease is liver cancer.